OMNIOX, INC.

Company Information

Company Name
OMNIOX, INC.
Address
75 Shoreway, Suite A
SAN CARLOS, CA, 94070-2727
Phone
n/a
URL
n/a
DUNS
786563036
Number of Employees
16
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$1,611,160.00
5
SBIR Phase II
$4,067,901.00
2
Chart code to be here

Award List

  1. TUMOR RADIOSENSITIZATION USING A NITRIC-OXIDE-NEUTRAL, TUNABLE OXYGEN-BINDING PRO

    Amount: $3,067,901.00

    DESCRIPTION (provided by applicant): Low oxygen conditions (hypoxia) commonly found in solid tumors are considered a major obstacle for the clinical management of cancer by radiation therapy (radiothe ...

    SBIR Phase II 2010 Department of Health and Human Services
  2. Targeted Oxygen Delivery to Wounds: Using a Novel, Tunable, Oxygen Delivery Tech

    Amount: $331,743.00

    DESCRIPTION (provided by applicant): This project will develop a novel class of oxygen binding proteins (H-NOX proteins) as a topical treatment for chronic wounds. These proteins are designed to p ...

    SBIR Phase I 2010 Department of Health and Human Services
  3. TUMOR RADIOSENSITIZATION USING A NITRIC-OXIDE-NEUTRAL, TUNABLE OXYGEN-BINDING PRO

    Amount: $480,058.00

    DESCRIPTION (provided by applicant): Low oxygen conditions (hypoxia) commonly found in solid tumors are considered a major obstacle for the clinical management of cancer by radiation therapy (radiothe ...

    SBIR Phase I 2008 Department of Health and Human Services
  4. TUMOR RADIOSENSITIZATION USING A NITRIC-OXIDE-NEUTRAL, TUNABLE OXYGEN-BINDING PRO

    Amount: $1,000,000.00

    PROJECT SUMMARY/ABSTRACT Through Phase I and II SBIR NCI support, Omniox has developed a breakthrough oxygen carrying protein, OMX-4.80, that delivers oxygen to tumors and greatly reduces hypoxia. Th ...

    SBIR Phase II 2012 Department of Health and Human Services
  5. Improving Chemotherapy with a Novel Oxygen-Delivery Protein

    Amount: $300,000.00

    Omniox has identified a breakthrough tunable oxygen (O2) delivery technology that perfuses deep into tumors and eliminates hypoxia. Hypoxia, a prominent feature in solid tumors, affects multiple cha ...

    SBIR Phase I 2012 Department of Health and Human Services
  6. Reducing Brain Injury After Focal Ischemia Using a Nitric Oxide-Neutral Oxygen Ca

    Amount: $274,359.00

    DESCRIPTION (provided by applicant): Omniox is developing a new oxygen delivery therapeutic (H-NOX) that has the potential to dramatically reduce the damage associated with stroke. Stroke causes the l ...

    SBIR Phase I 2012 Department of Health and Human Services
  7. Engineering of human H-NOX as an oxygen delivery therapeutic for prolonged admini

    Amount: $225,000.00

    Engineering'of'Human'H.NOX'as'an'Oxygen'Delivery'Therapeutic'for'Prolonged'Administration' ' ' Project Summary/Abstract Omniox has ...

    SBIR Phase I 2014 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government